Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer

AIM: Therapeutic efficacy of anticancer nanomedicine is compromised by tumor stromal barriers. The present study deals with the development of docetaxel loaded PEGylated liposomes (DTXPL) and to investigate the effect of tumor stroma disrupting agent, telmisartan, on anticancer efficacy of DTXPL. ME...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nanomedicine (Lond)
Hauptverfasser: Patel, Ketan, Doddapaneni, Ravi, Chowdhury, Nusrat, Boakye, Cedar HA, Behl, Gautam, Singh, Mandip
Format: Artigo
Sprache:Inglês
Veröffentlicht: Future Medicine Ltd 2016
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4910941/
https://ncbi.nlm.nih.gov/pubmed/27171485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nnm.16.37
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge